Search Results 391-400 of 17050 for monoclonal antibody

  1. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the patient's immune system attack the cancer, and may interfere with the ability ...

  2. BRCA Gene Test Clinical Trials - Mayo Clinic Research

    Denosumab is a monoclonal antibody that is used to treat bone loss in order to reduce the risk of bone fractures in healthy people, and to reduce new bone ...

  3. Viral hemorrhagic fevers - Diagnosis and treatment - Mayo Clinic

    And the Food and Drug Administration has approved monoclonal antibody therapies Inmazeb and Ebanga to treat Ebola. Therapy. Supportive care may help you feel ...

  4. Future therapy for Graves' ophthalmology - Mayo Clinic

    ... antibodies predict a worse prognosis. ... Bahn says: "We treated GO fibroblasts with a high-affinity human stimulatory monoclonal antibody directed against TSH ...

  5. Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery - Mayo Clinic

    About this study ... Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy ...

  6. Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant - Mayo Clinic

    Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of cancer cells to grow and spread. Drugs used in chemotherapy, such as ...

  7. Mayo Clinic Q and A: Treatment options for migraine

    The first calcitonin gene-related peptide monoclonal antibody to prevent migraine was approved in 2018. Today, four drugs have been approved: Eptinezumab ...

  8. Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery - Mayo Clinic

    Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  9. Recurrent Cancer Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Epacadostat may stop the growth of tumor ...

  10. Mayo Clinic Q & A - Dr. Gregory Poland COVID-19 Update 01 03...

    The extraordinary mutation of the Omicron variant has caused us to lose two sets of monoclonal antibodies, leaving us with one monoclonal antibody for ...